The Potential of High-Density Lipoprotein as a Predictive Biomarker for Infliximab Efficacy in Crohn’s Disease
The study adhered to the Declaration of Helsinki. All participants provided written informed consent, and the study was approved by the Ethics Committee of Xiangya Hospital, Central South University with approval No. 202108158.
Authors
- Kewei Tang (ORCID: https://orcid.org/0000-0002-7119-2690)
- Ziheng Peng (ORCID: https://orcid.org/0000-0002-8171-0252)
- xiaowei liu
- Guanghui Lian
- Yu Peng
- Duo Xu
- Yong Li
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
- South University (US)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/jir.s556975
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00